NCT01512966 - Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Macular Edema

Interventions

BIOLOGICAL

VEGF Trap-Eye (BAY86-5321)

Subjects in the VEGF Trap-Eye group will receive intravitreal injections every 8 weeks following a loading phase with injections given every 4 weeks. The overall treatment period is 48 weeks.

Trial Locations (18)

790-8524

Matsuyama

371-8511

Maebashi

650-0017

Kobe

310-0015

Mito

761-0793

Kita

890-8520

Kagoshima

216-8511

Kawasaki

606-8507

Kyoto

984-8560

Sendai

634-8522

Kashihara

700-8558

Okayama

537-0025

Osaka

558-8558

Osaka

565-0871

Suita

840-8571

Saga

520-2192

Ōtsu

329-0498

Shimotsuke

641-8510

Wakayama